CELUW supply chain intelligence for Celularity Inc: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Celularity Inc (CELUW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| CELUW-DEBT-8584 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2024-12-31. |
| CELUW-DEBT-8583 | Warrants outstanding: 892856 | 90% | xbrl warrant detail from xbrl 2024-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| DTIL | Precision BioSciences, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| SGMO | Sangamo Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ATRA | Atara Biotherapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ALLO | Allogene Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| IPSC | Century Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| NTLA | Intellia Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ORGO | Organogenesis Holdings Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ADAPY | Adaptimmune Therapeutics PLC | 100.00 | 1 | ['customer', 'supplier'] |
| BMY | Bristol-Myers Squibb Company | 50.00 | 2 | |
| CELU | Celularity Inc. | 50.00 | 2 | |
| CLLS | Cellectis S.A. | 50.00 | 2 | |
| CRBU | Caribou Biosciences, Inc. | 50.00 | 2 | |
| FATE | Fate Therapeutics, Inc. | 50.00 | 2 | |
| INAB | IN8bio, Inc. | 50.00 | 2 | |
| IONS | Ionis Pharmaceuticals, Inc. | 50.00 | 2 | |
| KALV | KalVista Pharmaceuticals, Inc. | 50.00 | 2 | |
| KYTX | Kyverna Therapeutics, Inc. | 50.00 | 2 | |
| LGND | Ligand Pharmaceuticals Incorporated | 50.00 | 2 | |
| NKTR | Nektar Therapeutics | 50.00 | 2 | |
| PFE | Pfizer Inc. | 50.00 | 2 |
Celularity Inc's full supply chain is mapped here, 2 verified relationships in our database.
Subscribe, View plans →